ResearcherOslo University HospitalActive in the last 2 years

Biswajyoti Sahu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6576-5440; OpenAlex author ID A5067387478. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper

Papers 1

NFATC2 in pancreatic cancer-associated fibroblasts predicts treatment response and facilitates ERBB-targeted therapies Last author DOI 10.64898/2026.04.04.716465 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tero A. Aittokallio · 1 shared paper, 2026 · strength 0.29
- Paper NFATC2 in pancreatic cancer-associated fibroblasts predicts treatment response and facilitates ERBB-targeted therapies DOI 10.64898/2026.04.04.716465 ↗
Jiahao Guo · 1 shared paper, 2026 · strength 0.29
- Paper NFATC2 in pancreatic cancer-associated fibroblasts predicts treatment response and facilitates ERBB-targeted therapies DOI 10.64898/2026.04.04.716465 ↗
Caroline Sophie Verbeke · 1 shared paper, 2026 · strength 0.29
- Paper NFATC2 in pancreatic cancer-associated fibroblasts predicts treatment response and facilitates ERBB-targeted therapies DOI 10.64898/2026.04.04.716465 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.